Commonly used gene therapy strategies using lentivirus infection involve preferential integration of a lentivirus to active transcription units, a process that is mediated by the host protein lens epithelium-derived growth factor (LEDGF/p75), which interacts with the lentiviral integrases [189]. The gene discussed is PSIP1; the disease is lentivirus infection.